Marvell Technology 

C$45.77
3154
+C$4.58+11.12% Thursday 19:59

Statistics

Day High
45.77
Day Low
45.77
52W High
52.35
52W Low
26
Volume
25,100
Avg. Volume
-
Mkt Cap
0
P/E Ratio
10.64
Dividend Yield
-
Dividend
-

Upcoming

Earnings

20AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.59
0.7
0.81
0.92
Expected EPS
0.922258
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MRV.TO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
NVIDIA
NVDA
Mkt Cap4.97T
NVIDIA Corporation is a direct competitor in the semiconductor space, particularly in areas like AI, data center, and networking solutions, overlapping with Marvell's product offerings.
Intel
INTC
Mkt Cap498.43B
Intel Corporation competes with Marvell in the data center and cloud computing markets, offering processors and solutions that directly compete with Marvell's storage, networking, and security products.
AMD
AMD
Mkt Cap760.48B
Advanced Micro Devices, Inc. is a competitor in the semiconductor industry, offering products that compete with Marvell's in the data center, server processors, and networking solutions.
Qualcomm
QCOM
Mkt Cap227.6B
Qualcomm Incorporated competes with Marvell in the networking and semiconductor sectors, especially in wireless technology and chips for telecommunications, an area where Marvell also operates.
Texas Instruments
TXN
Mkt Cap259.43B
Texas Instruments Incorporated competes with Marvell in the semiconductor market, particularly in the analog IC and embedded processing segments, which can overlap with Marvell's product lines.
Microchip Technology
MCHP
Mkt Cap47.89B
Microchip Technology Incorporated offers microcontroller, mixed-signal, analog, and Flash-IP solutions, competing with Marvell in the semiconductor space, particularly in embedded systems and IoT.
Analog Devices
ADI
Mkt Cap195.51B
Analog Devices, Inc. competes with Marvell in the semiconductor industry, particularly in the mixed-signal and digital signal processing (DSP) areas, which are crucial for networking and telecommunications.

About

Nuvo Pharmaceuticals Inc., doing business as Miravo Healthcare, provides prescription and non-prescription products for pain, allergy, neurology, and dermatology worldwide. The company operates in three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticaria; Cambia, a nonsteroidal anti-inflammatory drug for migraine; Suvexx/Treximet, a migraine medicine; NeoVisc, an injectable viscosupplement for osteoarthritis; and Resultz, FullMarks, and LAUSBUB for head lice infestations. The company also provides Bezalip SR for patients with high cholesterol or high levels of triglycerides; Proferrin, an iron supplement for the prevention and treatment of iron deficiency; Fiorinal 1 and Fiorinal C1 for the relief of tension-type headaches; Collatamp G for surgical implantation during surgery; PegaLAX, a laxative for the treatment of occasional constipation and irregularity; Mutaflor, a probiotic for the management and relief of chronic constipation and associated abdominal pain and cramps; MoviPrep for the cleansing of the colon in preparation for colonoscopy; and Soriatane to treat psoriasis and other keratinization disorders. In addition, it offers Pennsaid and Pennsaid 2% topical treatments for osteoarthritic pain; Vimovo for relief of arthritis symptoms; SYNERA and RAPYDAN topical patches used to help prevent pain associated with needle sticks and other superficial skin procedures; Yosprala for the prevention of heart attacks and strokes; and Heated Lidocaine/Tetracaine Patch, a topical patch applied prior to painful medical procedures. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was incorporated in 1983 and is headquartered in Mississauga, Canada. As of March 14, 2023, Nuvo Pharmaceuticals Inc. operates as a subsidiary of Searchlight Pharma Inc.
Show more...
CEO
Country
Canada
ISIN
CA5738711004

Listings

0 Comments

Share your thoughts

FAQ

What is Marvell Technology stock price today?
The current price of MRV.TO is C$45.77 CAD — it has increased by +11.12% in the past 24 hours. Watch Marvell Technology stock price performance more closely on the chart.
What is Marvell Technology stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Marvell Technology stocks are traded under the ticker MRV.TO.
When is the next Marvell Technology earnings date?
Marvell Technology is going to release the next earnings report on August 20, 2026.
What were Marvell Technology earnings last quarter?
MRV.TO earnings for the last quarter are 1.11 CAD per share, whereas the estimation was 1.11 CAD resulting in a +0.21% surprise. The estimated earnings for the next quarter are N/A CAD per share.
In which sector is Marvell Technology located?
Marvell Technology operates in the Other sector.
When did Marvell Technology complete a stock split?
Marvell Technology has not had any recent stock splits.